The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Immune complex–mediated antigen presentation induces tumor immunity
Abstract
Antigen uptake receptors on dendritic cells (DCs) provide efficient entry for the initiation of antigen-specific adaptive immunity. Here we show that targeting of antigen to Fc receptors on DCs accomplishes combined activation of Th1 CD4 and CD8 effector responses in vivo, namely delayed-type hypersensitivity and tumor immunity. Tumor immunity specific for ovalbumin-expressing tumors was provided by immunization with wild-type but not FcγRγ–/– DCs loaded with ovalbumin-containing immune complexes. Tumor protection was eliminated when immune complex–loaded DCs lacked β2 microglobulin, TAP, or MHC class II, demonstrating that Fc receptor–targeted antigenic uptake led to both MHC class I– and class II–restricted responses, which together are required for effector tumor immunity. Thus the cross-presentation pathway accessed by antigens acquired endocytically through Fc receptors links humoral and cellular immunity. These data suggest that administration of antitumor antibodies may enhance tumor-specific T cell responses in vivo and provide the rationale for Fc receptor targeting in vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Lutz, M. B., Kukutsch, N., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,966
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768 · cited 2×
“Genetic evidence in humans (15) and mice (16, 17) supports a general requirement for FcγRs engagement for the efficacy of antitumor antibodies in vivo, implicating Fc-dependent effector ADCC as a common mechanism underlying tumor-specific humoral immunity.”
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Mellman, I., & Steinman, R. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00449-4 · Cited by 2,237
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,283
FcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951
Self-citationRegnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Théry, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.371 · Cited by 898
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.65 · Cited by 725
The role of CD4+ T cell responses in antitumor immunity
Pardoll, D. M., & Topalian, S. L. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80228-8 · Cited by 672 · cited 2×
“Our data cannot distinguish whether IC-induced Th1 CD4 responses collaborate with CD8 cellular cytotoxicity by providing IFN-γ to augment CD8 responses during sensitization (41) and/or at the effector level (30, 31).”
CD4 T Cells and Their Role in Antitumor Immune Responses
Toes, R. E. M., Ossendorp, F., Offringa, R., & Melief, C. J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.753 · Cited by 508
Transport of Peptide-MHC Class II Complexes in Developing Dendritic Cells
Turley, S. J., Inaba, K., Garrett, W. S., Ebersold, M., Unternaehrer, J., Steinman, R. M., & Mellman, I. (2000) · Science · doi:10.1126/science.288.5465.522 · Cited by 477
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone, F. R., & Bevan, M. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.2.377 · Cited by 402
DIVERGENT ROLES FOR F c RECEPTORS AND COMPLEMENT IN VIVO
Ravetch, J. V., & Clynes, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.421 · Cited by 366
Self-citationRegulation of Antibody Responses via Antibodies, Complement, and Fc Receptors
Heyman, B. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.709 · Cited by 353
Dhodapkar, K. M., Krasovsky, J., Williamson, B., & Dhodapkar, M. V. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011097 · Cited by 349
Fc receptors are required in passive and active immunity to melanoma
Clynes, R., Takechi, Y., Moroi, Y., Houghton, A., & Ravetch, J. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.652 · Cited by 321
Self-citationIoan-Facsinay, A., de Kimpe, S. J., Hellwig, S. M. M., van Lent, P. L., Hofhuis, F. M. A., van Ojik, H. H., Sedlik, C., da Silveira, S. A., Gerber, J., de Jong, Y. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00294-7 · Cited by 304
Berard, F., Blanco, P., Davoust, J., Neidhart-Berard, E.-M., Nouri-Shirazi, M., Taquet, N., Rimoldi, D., Cerottini, J. C., Banchereau, J., & Palucka, A. K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1535 · Cited by 284
Nouri-Shirazi, M., Banchereau, J., Bell, D., Burkeholder, S., Kraus, E. T., Davoust, J., & Palucka, K. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3797 · Cited by 242
Schuurhuis, D. H., Ioan-Facsinay, A., Nagelkerken, B., van Schip, J. J., Sedlik, C., Melief, C. J. M., Verbeek, J. S., & Ossendorp, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2240 · Cited by 238
Hoffmann, T. K., Meidenbauer, N., Dworacki, G., Kanaya, H., & Whiteside, T. L. (2000) · PubMed · Cited by 227
In Vivo Cross-Priming of MHC Class I–Restricted Antigens Requires the TAP Transporter
Huang, A. Y. C., Bruce, A. T., Pardoll, D. M., & Levitsky, H. I. (1996) · Immunity · doi:10.1016/s1074-7613(00)80248-4 · Cited by 224
LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production.
Salomon, B. L., & Bluestone, J. A. (1998) · PubMed · Cited by 198
Heijnen, I. A., van Vugt, M. J., Fanger, N. A., Graziano, R. F., de Wit, T. P., Hofhuis, F. M., Guyre, P. M., Capel, P. J., Verbeek, J. S., & van de Winkel, J. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118420 · Cited by 185
Gosselin, E. J., Wardwell, K., Gosselin, D. R., Alter, N., Fisher, J. L., & Guyre, P. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3477 · Cited by 174
Jenne, L., Arrighi, J.-F., Jonuleit, H., Saurat, J. ‐., & Hauser, C. (2000) · PubMed · Cited by 159
Fc receptor signaling and trafficking: a connection for antigen processing
Amigorena, S., & Bonnerot, C. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01372.x · Cited by 122
Fc receptors for IgG and antigen presentation on MHC class I and class II molecules
Amigorena, S., & Bonnerot, C. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0196 · Cited by 88
Amigorena, S., Lankar, D., Briken, V., Gapin, L., Viguier, M., & Bonnerot, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.505 · Cited by 87
Schnell, S., Young, J. W., Houghton, A. N., & Sadelain, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1243 · Cited by 65
Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma
Honeychurch, J., Tutt, A. L., Valerius, T., Heijnen, I., van de Winkel, J. G. J., & Glennie, M. J. (2000) · Blood · doi:10.1182/blood.v96.10.3544 · Cited by 61
Hoffmann, T. K., Meidenbauer, N., Müller‐Berghaus, J., Storkus, W. J., & Whiteside, T. L. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00011 · Cited by 60
Targeting Weak Antigens to CD64 Elicits Potent Humoral Responses in Human CD64 Transgenic Mice
Keler, T., Guyre, P. M., Vitale, L. A., Sundarapandiyan, K., van de Winkel, J. G. J., Deo, Y. M., & Graziano, R. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6738 · Cited by 57
Regulation of IgG antibody titers by the amount persisting of immune‐complexed antigen
Bachmann, M. F., Kündig, T. M., Hengartner, H., & Zinkernagel, R. M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241046 · Cited by 53
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Fcγ Receptors: Old Friends and New Family Members
Nimmerjahn, F., & Ravetch, J. V. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.010 · Cited by 1,072
Engineered antibody Fc variants with enhanced effector function
Lazar, G. A., Dang, W., Karki, S., Vafa, O., Peng, J. S., Hyun, L., Chan, C., Chung, H. S., Eivazi, A., Yoder, S. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508123103 · Cited by 803
Metadata
- Authors
- Rafiq, K., Bergtold, A., & Clynes, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-07-01
- Volume
- 110
- Issue
- 1
- Pages
- 71-79
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4242972998
- Cited by
- 232
- References
- 41
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.